On September 4, CHINA LIFE rose 3.34% in regular trading, trading at 30.94 HKD/share, with turnover of 2.97 billion HKD. The rally was driven by the company's recently disclosed interim results and a generous dividend increase.

The company reported H1 attributable net profit of 134.489 billion yuan, surging 228.6% year-over-year to lead all five major listed insurers. Revenue reached 434.307 billion yuan, up 81.5%. Q2 standalone net profit soared 848% YoY to 114.984 billion yuan. Total investment income hit 314.504 billion yuan, fueled by a bond bull market and A-share recovery, with equity allocation rising to a record 19.16%.

The board proposed an interim dividend of 0.358 yuan per share, totaling approximately 10.119 billion yuan, up 50.4% YoY, marking the first time interim dividends exceeded 10 billion yuan. CMB International raised its target price to 39 HKD, maintaining a Buy rating, citing strong performance across underwriting and investment operations. Insurance sector peers also traded higher, with the broader sector benefiting from improved investment returns and institutional expectations of valuation recovery from low levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)